Loading clinical trials...
Loading clinical trials...
A Phase 1, Randomized, Placebo-controlled, Double-blind, Multiple Ascending Dose Trial to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VIS954 in Healthy Participants
Conditions
Interventions
VIS954
Placebo
Locations
1
United States
Anaheim Clinical Trials, LLC
Anaheim, California, United States
Start Date
March 13, 2025
Primary Completion Date
January 6, 2026
Completion Date
February 13, 2026
Last Updated
August 21, 2025
NCT06290258
NCT00090662
NCT06716502
NCT07310264
NCT07483606
NCT07310901
Lead Sponsor
Visterra, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions